Cognitive and Memory Enhancer Drugs Market 2028 By Drug Type, Application and Geography | The Insight Partners

report image

Cognitive and Memory Enhancer Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Type (Adderall, Provigil, Razadyne, Aricept, Namenda, Ritalin, Exelon, Others); Application (Disease Treatment, Academic Performance, Athletic Performance, Others) and Geography

Report Code: TIPRE00003844 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Cognitive and memory enhancers are the supplements or drugs, which assist to improve the cognitive functions such as creativity, memory, and others in patients suffering from diseases and disorders such as neurological disorders as well as in healthy individuals. The growth in the geriatric population, which is prone to neurological disorders such as Alzheimer's, is one of the primary drivers driving market growth. Furthermore, the market is expected to grow due to the increase in the usage of cognitive drugs due to their benefits, which include enhanced physical and mental performance.


The "Global Cognitive and Memory Enhancer Drugs Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the cognitive and memory enhancer drugs market with detailed market segmentation by drug type and application. The report provides key statistics on the market status of the leading cognitive and memory enhancer drugs market players and offers key trends and opportunities in the market.


  •   Based on drug type the market is segmented as, aricept, razadyne, exelon, namenda, provigil, ritalin, adderall and others.
  •   Based on application the market is segmented as, disease treatment, academic performance, athletic performance and others.



  •   Increasing geriatric population and growing prevalence of people suffering from neurodegenerative diseases like Alzheimer's disease.
  •   Moreover, the benefits offered by cognitive and memory enhancer drugs, such as enhanced physical and mental performance, are expected to fuel market growth.
  •   Increased healthcare expenditures along with presence of robust pipeline of agents is also expected to spur the market growth during the forecast period.


  •   However, ethical issues present with the use of such sort of drugs is expected to restrain market growth during the forecast period.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The cognitive and memory enhancer drugs market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the cognitive and memory enhancer drugs market in these regions.

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.


The report covers key developments in the cognitive and memory enhancer drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from cognitive and memory enhancer drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for cognitive and memory enhancer drugs in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the cognitive and memory enhancer drugs market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Eisai Co., Ltd.
  •   Pfizer Inc
  •   Johnson and Johnson Services, Inc
  •   Alternascript
  •   Lundbeck
  •   Novartis AG
  •   Lilly
  •   Takeda Pharmaceutical Company Limited
  •   F. Hoffmann-La Roche Ltd
  •   Sanofi
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
The List of Companies

1. Eisai Co., Ltd.
2. Pfizer Inc
3. Johnson and Johnson Services, Inc
4. Alternascript
5. Lundbeck
6. Novartis AG
7. Lilly
8. Takeda Pharmaceutical Company Limited
9. F. Hoffmann-La Roche Ltd
10. Sanofi
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount